Drug trial failures gives CSL $8b of heart palpitations
MELBOURNE: On one view, the failure of CSL’s much anticipated heart-attack drug is a symbol
MELBOURNE: On one view, the failure of CSL’s much anticipated heart-attack drug is a symbol